These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24346129)

  • 21. Implication of miRNA in the diagnosis and treatment of breast cancer.
    Castañeda CA; Agullo-Ortuño MT; Fresno Vara JA; Cortes-Funes H; Gomez HL; Ciruelos E
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1265-75. PubMed ID: 21916580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular classification of breast cancer: limitations and potential.
    Pusztai L; Mazouni C; Anderson K; Wu Y; Symmans WF
    Oncologist; 2006 Sep; 11(8):868-77. PubMed ID: 16951390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiling of breast cancer.
    Cheang MC; van de Rijn M; Nielsen TO
    Annu Rev Pathol; 2008; 3():67-97. PubMed ID: 18039137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Predictive and prognostic markers of breast cancer. Molecular biological analysis of fixed tumor tissue].
    Petry C; Gehrmann M; von Törne C; Weber K; Stropp U; Hennig G
    Pathologe; 2008 Nov; 29 Suppl 2():181-3. PubMed ID: 18843491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular profiling: moving away from tumor philately.
    Reis-Filho JS; Weigelt B; Fumagalli D; Sotiriou C
    Sci Transl Med; 2010 Sep; 2(47):47ps43. PubMed ID: 20811040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Signal transduction and its targeting from the cancer molecular genetic platform: applications and perspectives in pulmonary pathology].
    Merlio JP
    Ann Pathol; 2011 Nov; 31(5 Suppl):S40-2. PubMed ID: 22054456
    [No Abstract]   [Full Text] [Related]  

  • 28. Microarrays in cancer: research and applications.
    Ochs MF; Godwin AK
    Biotechniques; 2003 Mar; Suppl():4-15. PubMed ID: 12664679
    [No Abstract]   [Full Text] [Related]  

  • 29. Hereditary breast-ovarian cancer: how can we use the new DNA markers to improve patient management?
    Narod S
    Clin Invest Med; 1993 Aug; 16(4):314-7. PubMed ID: 8306541
    [No Abstract]   [Full Text] [Related]  

  • 30. CHEK2 1100delC and Del5395bp mutations in BRCA-negative individuals from Serbian hereditary breast and ovarian cancer families.
    Krivokuca A; Dobricic J; Brankovic-Magic M
    J BUON; 2013; 18(3):594-600. PubMed ID: 24065469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer pathology: the impact of molecular taxonomy on morphological taxonomy.
    Masuda S
    Pathol Int; 2012 May; 62(5):295-302. PubMed ID: 22524656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma.
    Silva J; Silva JM; García V; García JM; Domínguez G; Bonilla F
    Genes Chromosomes Cancer; 2002 Dec; 35(4):375-6. PubMed ID: 12378534
    [No Abstract]   [Full Text] [Related]  

  • 33. [Molecular factors determine primary and secondary therapy of breast carcinoma].
    Eppenberger U; Kueng W; Eppenberger-Castori S; von Landenberg EM; Müller H
    Ther Umsch; 1997 Aug; 54(8):451-6. PubMed ID: 9381415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-10b and breast cancer metastasis.
    Gee HE; Camps C; Buffa FM; Colella S; Sheldon H; Gleadle JM; Ragoussis J; Harris AL
    Nature; 2008 Oct; 455(7216):E8-9; author reply E9. PubMed ID: 18948893
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular determinants of occult metastatic tumor cells in bone marrow.
    Pantel K; Braun S
    Clin Breast Cancer; 2001 Oct; 2(3):222-8. PubMed ID: 11899416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic inactivation of DNA repair in breast cancer.
    Nowsheen S; Aziz K; Tran PT; Gorgoulis VG; Yang ES; Georgakilas AG
    Cancer Lett; 2014 Jan; 342(2):213-22. PubMed ID: 22634493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic studies provide new insights into breast cancer biology and treatment.
    Hampton T
    JAMA; 2013 Feb; 309(5):427-9. PubMed ID: 23385246
    [No Abstract]   [Full Text] [Related]  

  • 39. [Genomics and clinical research for breast cancer].
    Bertucci F; Birnbaum D
    Med Sci (Paris); 2012 Mar; 28 Spec No 1():14-8. PubMed ID: 22494651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
    Shi M; Guo N
    Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.